UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Clinical cancer research, 2008-01, Vol.14 (1), p.155-161

2008

Volltextzugriff (PDF)

Are Biosimilars the Future of Oncology and Haematology?

Drugs (New York, N.Y.), 2019-10, Vol.79 (15), p.1609-1624

2019

Volltextzugriff (PDF)

RANK Induces Epithelial―Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis

Cancer research (Chicago, Ill.), 2012-06, Vol.72 (11), p.2879-2888

2012

Volltextzugriff (PDF)

Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation

Bone marrow transplantation (Basingstoke), 2020-12, Vol.55 (12), p.2261-2269

2020

Volltextzugriff (PDF)

Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation

Stem cells (Dayton, Ohio), 2016-04, Vol.34 (4), p.1027-1039

2016

Volltextzugriff (PDF)

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

The lancet oncology, 2020-07, Vol.21 (7), p.978-988

2020

Volltextzugriff (PDF)

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

Frontiers in oncology, 2023-08, Vol.13, p.1220305-1220305

2023

Volltextzugriff (PDF)

Chromosome 12p Amplification in Triple-Negative/ BRCA1- Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (16), p.4258-4270

2019

Volltextzugriff (PDF)

RANKL inhibition: a promising novel strategy for breast cancer treatment

Clinical & translational oncology, 2011-04, Vol.13 (4), p.222-228

González-Suárez, Eva

2011

Volltextzugriff (PDF)

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in oncology, 2022-06, Vol.12, p.889575-889575

2022

Volltextzugriff (PDF)

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

Hematological oncology, 2017-12, Vol.35 (4), p.520-527

2017

Volltextzugriff (PDF)

Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer

Molecular & cellular oncology, 2017-07, Vol.4 (4), p.e1338208-e1338208

2017

Volltextzugriff (PDF)

Correction to: Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential

Journal of mammary gland biology and neoplasia, 2023-12, Vol.28 (1), p.4-4, Article 4

2023

Volltextzugriff (PDF)

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

Oncotarget, 2015-12, Vol.6 (42), p.44254-44273

2015

Volltextzugriff (PDF)

Rank ectopic expression in the presence of Neu and MMTV oncogenes alters mammary epithelial cell populations and their tumorigenic potential

Journal of mammary gland biology and neoplasia, 2023-12, Vol.28 (1), p.2-2

2023

Volltextzugriff (PDF)

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells

Cancer cell, 2018-06, Vol.33 (6), p.1094-1110.e8

2018

Volltextzugriff (PDF)

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Cancer research (Chicago, Ill.), 2016-10, Vol.76 (19), p.5857-5869

2016

Volltextzugriff (PDF)

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Breast cancer research and treatment, 2010-05, Vol.121 (1), p.257-260

2010

Volltextzugriff (PDF)

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4578-4584

2009

Volltextzugriff (PDF)

MicroRNA signatures in hereditary breast cancer

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.19-30

2013

Volltextzugriff (PDF)

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma

Clinical cancer research, 2021-03, Vol.27 (5), p.1491-1504

2021

Volltextzugriff (PDF)

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

Supportive care in cancer, 2021-06, Vol.29 (6), p.3121-3127

2021

Volltextzugriff (PDF)

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

Cancer reports, 2021-08, Vol.4 (4), p.e1358-n/a

2021

Volltextzugriff (PDF)

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Oncotarget, 2016-03, Vol.7 (9), p.10174-10181

2016

Volltextzugriff (PDF)

PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma

Oncogene, 2019-06, Vol.38 (25), p.5021-5037

2019

Volltextzugriff (PDF)

1 – 25 von 436

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(386)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication

Are Biosimilars the Future of Oncology and Haematology?

RANK Induces Epithelial―Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis

Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation

Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

Chromosome 12p Amplification in Triple-Negative/ BRCA1- Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity

RANKL inhibition: a promising novel strategy for breast cancer treatment

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer

Correction to: Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

Rank ectopic expression in the presence of Neu and MMTV oncogenes alters mammary epithelial cell populations and their tumorigenic potential

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

MicroRNA signatures in hereditary breast cancer

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma

Aktive Filter

Suchergebnisse filtern